| DNA vaccination against rat her-2/Neu p185 more effectively inhibits carcinogenesis than transplantable carcinomas in transgenic BALB/c mice S Rovero, A Amici, E Di Carlo, R Bei, P Nanni, E Quaglino, P Porcedda, ... The Journal of Immunology 165 (9), 5133-5142, 2000 | 407 | 2000 |
| Vaccines for tumour prevention PL Lollini, F Cavallo, P Nanni, G Forni Nature Reviews Cancer 6 (3), 204-216, 2006 | 360 | 2006 |
| Interleukin 12–mediated Prevention of Spontaneous Mammary Adenocarcinomas in Two Lines of Her-2/neu Transgenic Mice K Boggio, G Nicoletti, E Di Carlo, F Cavallo, L Landuzzi, C Melani, ... The Journal of experimental medicine 188 (3), 589-596, 1998 | 359 | 1998 |
| 2011: the immune hallmarks of cancer F Cavallo, C De Giovanni, P Nanni, G Forni, PL Lollini Cancer Immunology, Immunotherapy 60 (3), 319-326, 2011 | 323 | 2011 |
| Combined allogeneic tumor cell vaccination and systemic interleukin 12 prevents mammary carcinogenesis in HER-2/neu transgenic mice P Nanni, G Nicoletti, C De Giovanni, L Landuzzi, E Di Carlo, F Cavallo, ... The Journal of experimental medicine 194 (9), 1195-1206, 2001 | 284 | 2001 |
| Blockage of insulin-like growth factor-I receptor inhibits the growth of Ewing's sarcoma in athymic mice K Scotlandi, S Benini, P Nanni, PL Lollini, G Nicoletti, L Landuzzi, M Serra, ... Cancer research 58 (18), 4127-4131, 1998 | 237 | 1998 |
| Immunizing and curative potential of replicating and nonreplicating murine mammary adenocarcinoma cells engineered with interleukin (IL)-2, IL-4, IL-6, IL-7, IL-10, tumor … A Allione, M Consalvo, P Nanni, PL Lollini, F Cavallo, M Giovarelli, ... Cancer research 54 (23), 6022-6026, 1994 | 210 | 1994 |
| Inhibition of insulin-like growth factor I receptor increases the antitumor activity of doxorubicin and vincristine against Ewing’s sarcoma cells S Benini, MC Manara, N Baldini, V Cerisano, M Serra, M Mercuri, ... Clinical Cancer Research 7 (6), 1790-1797, 2001 | 177 | 2001 |
| Preclinical in vivo study of new insulin-like growth factor-I receptor–specific inhibitor in Ewing's sarcoma MC Manara, L Landuzzi, P Nanni, G Nicoletti, D Zambelli, PL Lollini, ... Clinical cancer research 13 (4), 1322-1330, 2007 | 167 | 2007 |
| TS/A: a new metastasizing cell line from a BALB/c spontaneous mammary adenocarcinoma P Nanni, C De Giovanni, PL Lollini, G Nicoletti, G Prodi Clinical & experimental metastasis 1 (4), 373-380, 1983 | 154 | 1983 |
| Retrogenic expression of the MET proto-oncogene correlates with the invasive phenotype of human rhabdomyosarcomas. R Ferracini, M Olivero, MF Di Renzo, M Martano, C De Giovanni, P Nanni, ... Oncogene 12 (8), 1697-1705, 1996 | 144 | 1996 |
| Effectiveness of insulin-like growth factor I receptor antisense strategy against Ewing's sarcoma cells K Scotlandi, C Maini, MC Manara, S Benini, M Serra, V Cerisano, ... Cancer gene therapy 9 (3), 296-307, 2002 | 135 | 2002 |
| Analysis of mammary carcinoma onset and progression in HER-2/neu oncogene transgenic mice reveals a lobular origin. E Di Carlo, MG Diodoro, K Boggio, A Modesti, M Modesti, P Nanni, ... Laboratory investigation; a journal of technical methods and pathology 79 …, 1999 | 129 | 1999 |
| Inhibition of tumor growth and enhancement of metastasis after transfection of the γ‐interferon gene PL Lollini, MC Bosco, F Cavallo, C De Giovanni, M Giovarelli, L Landuzzi, ... International journal of cancer 55 (2), 320-329, 1993 | 125 | 1993 |
| CD25+ regulatory T cell depletion augments immunotherapy of micrometastases by an IL-21-secreting cellular vaccine A Comes, O Rosso, AM Orengo, E Di Carlo, C Sorrentino, R Meazza, ... The Journal of Immunology 176 (3), 1750-1758, 2006 | 122 | 2006 |
| Ability of systemic interleukin-12 to hamper progressive stages of mammary carcinogenesis in HER2/neu transgenic mice K Boggio, E Di Carlo, S Rovero, F Cavallo, E Quaglino, PL Lollini, ... Cancer Research 60 (2), 359-364, 2000 | 119 | 2000 |
| Immunoprevention of mammary carcinoma in HER-2/neu transgenic mice is IFN-γ and B cell dependent P Nanni, L Landuzzi, G Nicoletti, C De Giovanni, I Rossi, S Croci, A Astolfi, ... The Journal of Immunology 173 (4), 2288-2296, 2004 | 118 | 2004 |
| Inhibition of connective tissue growth factor (CTGF/CCN2) expression decreases the survival and myogenic differentiation of human rhabdomyosarcoma cells S Croci, L Landuzzi, A Astolfi, G Nicoletti, A Rosolen, F Sartori, MY Follo, ... Cancer research 64 (5), 1730-1736, 2004 | 116 | 2004 |
| Molecular and cellular biology of rhabdomyosarcoma C De Giovanni, L Landuzzi, G Nicoletti, PL Lollini, P Nanni Future oncology 5 (9), 1449-1475, 2009 | 114 | 2009 |
| The metastatic ability of Ewing's sarcoma cells is modulated by stem cell factor and by its receptor c-kit L Landuzzi, C De Giovanni, G Nicoletti, I Rossi, C Ricci, A Astolfi, ... The American journal of pathology 157 (6), 2123-2131, 2000 | 114 | 2000 |
